FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...

Two-Pill Combo Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML

By Dennis Thompson HealthDay ReporterFRIDAY, June 5, 2026 (HealthDay News) — An already available two-pill combo treats ...

New targeted combination in people with relapsed acute myeloid leukemia shows promise

New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational ...

Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AML

Surveyed oncologists reported high likelihood to prescribe (6 of 7), citing deep remissions, transplant-bridging potential, biomarker-agnostic ...
Oncology Nurse Advisor

Selinexor May Improve Clinical Outcomes in AML, Further Study Needed

Researchers sought to determine whether adding selinexor to chemotherapeutic induction and consolidation regimen would improve outcomes in AML.
Morningstar

Blood Cancer United Expands its Beat AML® Master Clinical Trial Advancing Next-Generation Treatment

WASHINGTON, Jan. 14, 2026 /PRNewswire/ -- Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today that the first patient has received treatment in a new sub-study of its Beat ...

ASCO 2026 | Updated Data from an Oral Presentation of InnoCare's Novel BCL2 Inhibitor Mesutoclax in MDS and AML Released

As of April 20, 2026, among evaluable treatment-naïve (TN) MDS patients, the overall response rate (ORR) per IWG 2006 criteria was 100%, including a complete response (CR) rate of 40%, and marrow CR ...

Blood Cancer United Data at 2026 ASCO and EHA Highlight Beat AML Progress, Patient Experience Insights and Access Barriers

Blood Cancer United announced today that new data across its portfolio of funded research will be presented in more than 50 ...
AOL

What cancer did Tatiana Schlossberg have? Acute myeloid leukemia, explained.

Tatiana Schlossberg, President John F. Kennedy's granddaughter and Caroline Kennedy's daughter, has died at 35, shortly after revealing a terminal cancer diagnosis of acute myeloid leukemia. In a ...